Xinyu Pharmaceutical Co., Ltd.
Address: 158, Jintai 5th Road, Economic
development zone, Suzhou, Anhui, China
E-mail: seco@xinyupharm.cn
Tel: +86-557-3621963
Contact: Ma Hongjuan +86-13696716656
Fax: +86-557-3622061
Website: www.xinyupharm.cn
Clindamycin Phosphate (APIs)
Quality standard:CHP/USP/EP
Registered trademark:Wanbei
Specification:20kg/drum
Sales tel: +86-557-3621963 Contact: Guo Fei +86-13805578207 E-sales: seco@xinyupharm.cn
Clindamycin Phosphate has strong antimicrobial activity on gram-positive bacterium, especially for anaerobic bacteria.
In October, 2015, bulk drug of Clindamycin Phosphate was awarded title of “Anhui industrial competitive products”;
In December, 2015, our invention patent-crystallization method of Clindamycin Phosphate, was awarded of Anhui excellent patent;
The project of new technique research and industrialization of Clindamycin Phosphate, won 3rd prize of scientific and technological progress in 2013;
In April, 2013, production line of bulk drug of Clindamycin Phosphate, got EU CEP certificate;
In 2008, new synthesis technique of Clindamycin Phosphate passed authentication of Anhui science and technology bureau.
[ English name ]Clindamycin Phosphate
[ Pinyin ]Kelinmeisu Linsuanzhi
[ Structural formula ]
.jpg)
[ Molecular formula ]C18H34ClN2O8PS
[ Molecular weight ]504.97
[ Appearance ]white or almost white crystal powder, odorless, bitter taste
[ Function and effect ]
Cilindamycin phosphatehas strong antimicrobial activity on Gram-positive cocci and anaerobic bacteria.
Quality standard
| Item | USP standard | EP standard | ChP standard |
| Content | ≥758μg/mg (as clindamycin) |
96.0-102.0% (as clindamycin phosphate) |
≥77.0% (as clindamycin) |
| relative substance | lincomycin phosphate≤1.0% | impurity B≤1.0% | lincomycin ≤0.2% |
| lincomycin ≤0.5% | impurity L≤1.0% | clindamycin≤0.5% | |
| clindamycinB phosphate≤1.5% | impurity E≤0.5% | clindamycinB phosphate≤1.5% | |
| 7-clindamycin phosphate≤0.8% | impurity F ≤0.5% | impurity A≤1.5% | |
| clindamycin3 phosphate≤0.3% | impurity G≤0.2% | / | |
| clindamycin≤0.5% | impurity I≤0.2% | / | |
| clindamycin≤0.5% | impurity J≤0.2% | / | |
| / | impurity K≤0.2% | / | |
| other unkown impurity≤1.0% | other unkown impurity≤0.10% | other single impurity ≤0.5% | |
| total impurity ≤4.0% | total impurity ≤2.0% | other impurity≤2.0% |